Who is sponsoring NCT05821829?

NCT05821829 is sponsored by University of Pisa.

What drugs are being tested in NCT05821829?

Interventions in NCT05821829: Intravascular litothripsy (IVL).

What condition does NCT05821829 study?

NCT05821829 studies Peripheral Arterial Disease, Common Femoral Artery Stenosis, Common Femoral Artery Occlusion, Critical Limb-Threatening Ischemia.

Is NCT05821829 still recruiting?

NCT05821829 is currently status unknown. Last updated 10 May 2023.

Last reviewed 2023-05-10 · How we verify

NCT05821829: FESTIVAL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endovascular Treatment of Primary Common FEmoral Artery atheroSclerotic Disease wiTh IntraVAscular Litothripsy

Status unknown Last updated 10 May 2023

What this trial tests

trial testing Intravascular litothripsy (IVL) in Peripheral Arterial Disease in 150 participants. Status unknown.

Timeline

1 May 2023

Primary endpoint
1 May 2024

1 May 2025

Quick facts

Lead sponsor	University of Pisa
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 May 2023
Primary completion	1 May 2024
Estimated completion	1 May 2025
Sites	1 location across Italy

Drugs / interventions tested

Intravascular litothripsy (IVL)

Conditions studied

Peripheral Arterial Disease — all drugs for Peripheral Arterial Disease →
Common Femoral Artery Stenosis — all drugs for Common Femoral Artery Stenosis →
Common Femoral Artery Occlusion — all drugs for Common Femoral Artery Occlusion →
Critical Limb-Threatening Ischemia — all drugs for Critical Limb-Threatening Ischemia →

Sponsor

University of Pisa

Who can join

Adults 18 to 99, any sex, with Peripheral Arterial Disease or Common Femoral Artery Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, nonrandomized, multicenter, national, multidisciplinary, real-world data collection with the aim to evaluate the short-term safety and efficacy of intravascular lithotripsy in the treatment of steno-obstructive disease of the common femoral artery

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Percutaneous Endovascular Reconstruction of the Common Femoral Artery and Its Bifurcation.
Rassam S, Coscas R. · · 2024 · cited 6× · PMID 38892880 · DOI 10.3390/jcm13113169

Verify or expand the search:

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

NCT05437562 — Randomized Clinical Trial for Ewing Amputation in the VA · NA · recruiting
NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
NCT07076082 — Vascular Trial Associated Registry Pilot · Phase 4 · recruiting
NCT06308562 — Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease · NA · recruiting

Other University of Pisa trials

Trials by the same sponsor.

NCT07520890 — Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs) · recruiting
NCT07444229 — Team-Based Learning Integrated Into Clinical Simulation in Nursing Students · NA · not yet recruiting
NCT07041983 — 24-h Energy Expenditure and Anti-obesity Medication · enrolling by invitation
NCT07510685 — Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial) · NA · completed
NCT07055152 — Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05821829 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pisa
Last refreshed: 10 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05821829.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing